following side effects
taking busulfan
check
doctor
nurse
hematologic side effects
myelosuppression
leukopenia
thrombocytopenia
anemia
frequent toxic effects
use of busulfan
active ingredient
busulfex
dose
limiting myelosuppression
main side effect with usual doses
postmarketing reports
febrile neutropenia
thrombotic microangiopathy
myelosuppression
myelosuppression
result of a failure
further drug administration in the face of an undetected decrease in leukocyte
platelet counts
high dose therapy
neutrophils
day
platelets
day
study
patients
busulfan
leukemia
corticosteroids
arresting
reversing
fibrosis in some cases
respiratory side effects
lung damage
patients with the higher doses
bone marrow transplant
interstitial pulmonary fibrosis
busulfan lung
immediate discontinuation of busulfan administration
presentation of symptoms
several years in many patients
slow onset of cough
dyspnea
low grade fever
clinician
infection
leukemia in the lungs
patients
pulmonary insufficiency
tachypnea
cyanosis
single case of pulmonary alveolar proteinosis
case of endocardial fibrosis
year-old woman
total dose
mg over a period of years for the management of chronic myelogenous leukemia
autopsy
endocardial fibrosis of the left ventricle in addition
interstitial pulmonary fibrosis
cardiovascular
side effects
moderate tachycardia
patients
patients
busulfan administration
other rhythm abnormalities
arrhythmia
atrial fibrillation
ventricular extrasystoles
third degree heart block
moderate thrombosis
patients
episodes
central venous catheter
hypertension
mild vasodilation
flushing
hot flashes
hypotension
other cardiovascular events
mild ecg abnormality
grade
left-sided heart failure
patient
moderate pericardial effusion
events
post-cyclophosphamide phase
case of endocardial fibrosis
ocular side effects
cataracts
vision changes
prolonged administration
drug
induced cataracts in rats
study
patients
busulfan
active ingredient
busulfex
bone marrow transplantation
degree of alopecia
patients
alopecia
patients
same dosage per kg
patients
higher blood concentrations
extensive alopecia
hyperpigmentation
patients with a dark complexion
cases of alopecia
dermatologic side effects
hyperpigmentation
skin
nails
hands
urticaria
erythema multiforme
erythema nodosum
alopecia
porphyria cutanea tarda
excessive dryness
fragility of the skin with anhidrosis
symptoms of the syndrome
adrenal insufficiency
drug
adrenal responsiveness
administered acth
pituitary function testing with metyrapone
hydroxycorticosteroid excretion
patients
following
discontinuation of the drug
clinical improvement
rechallenge with metyrapone
normal pituitary-adrenal function
adverse effects
increased urate pool
increased hydration
urine alkalinization
prophylactic administration of a xanthine oxidase inhibitor
allopurinol
metabolic side effects
several cases of a clinical syndrome
resembling
resembling adrenal insufficiency
weakness
severe fatigue
anorexia
weight loss
melanoderma
nausea
vomiting
prolonged therapy
postmarketing reports
tumor lysis syndrome
hyperuricemia
hyperuricosuria
patients with chronic myelogenous leukemia
additional rapid destruction of granulocytes
initiation of chemotherapy
urate pool
clinical examination
laboratory findings
hepatic veno-occlusive disease
patients
busulfan
active ingredient
busulfex
setting of allogeneic transplantation
cases
overall mortality from hepatic veno-occlusive disease in the entire study population
hepatic side effects
hepatic veno-occlusive disease
esophageal varices
patients
receiving busulfan in combination with thioguanine
jaundice
hepatitis
nervous system
side effects
seizures
fourth day in patients
receiving high dose therapy
study of bone marrow transplant recipients
received busulfan
cases of convulsions
patients
convulsions
anticonvulsants
study
patients
experienced seizures
been cases of busulfan-related seizures
literature
prophylactic anticonvulsant therapy
phenytoin
patients
receiving high dose busulfan
oncologic side effects
histologic changes in the urinary
respiratory tracts
uterine cervix
liver
international agency for research on cancer
iarc
activity of busulfan
active ingredient
busulfex
potential carcinogenicity
short-term tests
cases of endometrial cancer
case
years of treatment
other side effects in patients
receiving allogenic transplant
form of edema
hypervolemia
documented weight increase
events
genitourinary side effects
hemorrhagic cystitis
gynecomastia
amenorrhea
testicular atrophy
resulting in sterility
gastrointestinal side effects
dryness of the oral mucous membranes
cheilosis
musculoskeletal side effects
myasthenia gravis
postmarketing reports
cytomegalovirus viremia
fungal infections
sepsis
black, tarry stools
bloated abdomen
stomach
blood in the urine
stools
blurred vision
chest pain
cough or hoarseness
dizziness
irregular breathing
pounding
irregular heartbeat
pulse
fever or chills
headache
side pain
nervousness
pain
fullness in the upper abdominal
stomach
difficult urination
red spots on the skin
pounding in the ears
skin rash
itching
slow heartbeat
swelling of the eyes
eyelids
tightness in the chest
trouble breathing
unusual bleeding
bruising
weight gain
yellow eyes
skin
seizures
acid
sour stomach
back pain
belching
bloody nose
depression
diarrhea
difficulty
bowel movement
stool
fear
heartburn
indigestion
loss of appetite
lack
loss of strength
sneezing
stomach discomfort
upset
stuffy nose
runny nose
swelling
inflammation of the mouth
tenderness
pain
swelling
warmth
skin discoloration
prominent superficial veins over affected area
trouble sleeping